Effect of moderate vs mild therapeutic hypothermia on mortality and neurologic outcomes in comatose survivors of out-of-hospital cardiac arrest: The CAPITAL CHILL randomized clinical trial
JAMA Oct 23, 2021
Le May M, Osborne C, Russo J, et al. - Researchers investigated the effect of moderate (target temperature of 31 °C) vs mild hypothermia (target temperature of 34 °C) on the rate of death or poor neurologic outcome in comatose survivors of out-of-hospital cardiac arrest.
Single-center, double-blind, randomized, clinical superiority trial including 367 adults with out-of-hospital cardiac arrest.
Patients randomized to receive hypothermia treatment at 31 °C vs 34 °C had 180-day all-cause mortality or poor neurologic outcome of 48.4% vs 45.4%, respectively; no statistically significant value of this difference was evident.
Overall there appeared no significant reduction in the rate of death or poor neurologic outcome among comatose survivors of out-of-hospital cardiac arrest at 180 days in correlation with a target temperature of 31 °C vs 34 °C.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries